These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 9342375)
21. [Prospects for gene therapy for chronic granulomatous disease with gp91-phox deficiency]. Nunoi H; Sugimoto Y; Kanegasaki S Rinsho Ketsueki; 1998 Feb; 39(2):132. PubMed ID: 9545823 [No Abstract] [Full Text] [Related]
22. NADPH oxidase correction by mRNA transfection of apheresis granulocytes in chronic granulomatous disease. De Ravin SS; Brault J; Meis RJ; Li L; Theobald N; Bonifacino AC; Lei H; Liu TQ; Koontz S; Corsino C; Zarakas MA; Desai JV; Clark AB; Choi U; Metzger ME; West K; Highfill SL; Kang E; Kuhns DB; Lionakis MS; Stroncek DF; Dunbar CE; Tisdale JF; Donahue RE; Dahl GA; Malech HL Blood Adv; 2020 Dec; 4(23):5976-5987. PubMed ID: 33284949 [TBL] [Abstract][Full Text] [Related]
23. [Clinical and molecular characterization of autosomal recessive chronic granulomatous disease caused by p47-phox deficiency]. Cornejo De Luigi M; López JA; Navarro S; García D; Patiño PJ Rev Med Chil; 2000 May; 128(5):491-8. PubMed ID: 11008352 [TBL] [Abstract][Full Text] [Related]
24. Peripheral blood progenitors as a target for genetic correction of p47phox-deficient chronic granulomatous disease. Sekhsaria S; Gallin JI; Linton GF; Mallory RM; Mulligan RC; Malech HL Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7446-50. PubMed ID: 8395049 [TBL] [Abstract][Full Text] [Related]
25. Expansion of genetically corrected neutrophils in chronic granulomatous disease mice by cotransferring a therapeutic gene and a selective amplifier gene. Hara T; Kume A; Hanazono Y; Mizukami H; Okada T; Tsurumi H; Moriwaki H; Ueda Y; Hasegawa M; Ozawa K Gene Ther; 2004 Sep; 11(18):1370-7. PubMed ID: 15229634 [TBL] [Abstract][Full Text] [Related]
26. Successful immune reconstitution by means of hematopoietic stem cell transplantation in a Colombian patient with chronic granulomatous disease. Rocha YC; López JÁ; Orrego JC; Coll Y; Karduss A; Rosenzweig S; Franco JL Biomedica; 2016 Jun; 36(2):204-12. PubMed ID: 27622481 [TBL] [Abstract][Full Text] [Related]
27. Retroviral marking and transplantation of rhesus hematopoietic cells by nonmyeloablative conditioning. Huhn RD; Tisdale JF; Agricola B; Metzger ME; Donahue RE; Dunbar CE Hum Gene Ther; 1999 Jul; 10(11):1783-90. PubMed ID: 10446918 [TBL] [Abstract][Full Text] [Related]
36. Transplantation of a fetus with paternal Thy-1(+)CD34(+)cells for chronic granulomatous disease. Muench MO; Rae J; Bárcena A; Leemhuis T; Farrell J; Humeau L; Maxwell-Wiggins JR; Capper J; Mychaliska GB; Albanese CT; Martin T; Tsukamoto A; Curnutte JT; Harrison MR Bone Marrow Transplant; 2001 Feb; 27(4):355-64. PubMed ID: 11313664 [TBL] [Abstract][Full Text] [Related]
37. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Güngör T; Teira P; Slatter M; Stussi G; Stepensky P; Moshous D; Vermont C; Ahmad I; Shaw PJ; Telles da Cunha JM; Schlegel PG; Hough R; Fasth A; Kentouche K; Gruhn B; Fernandes JF; Lachance S; Bredius R; Resnick IB; Belohradsky BH; Gennery A; Fischer A; Gaspar HB; Schanz U; Seger R; Rentsch K; Veys P; Haddad E; Albert MH; Hassan M; Lancet; 2014 Feb; 383(9915):436-48. PubMed ID: 24161820 [TBL] [Abstract][Full Text] [Related]
38. In vitro molecular reconstitution of the respiratory burst in B lymphoblasts from p47-phox-deficient chronic granulomatous disease. Volpp BD; Lin Y J Clin Invest; 1993 Jan; 91(1):201-7. PubMed ID: 7678602 [TBL] [Abstract][Full Text] [Related]
39. Protein delivery by Pseudomonas type III secretion system: Ex vivo complementation of p67(phox)-deficient chronic granulomatous disease. Polack B; Vergnaud S; Paclet MH; Lamotte D; Toussaint B; Morel F Biochem Biophys Res Commun; 2000 Sep; 275(3):854-8. PubMed ID: 10973811 [TBL] [Abstract][Full Text] [Related]